A 2025 study published in AJMC found that many patients who stopped semaglutide or tirzepatide in real-world settings did not regain weight as rapidly as clinical trial outcomes suggested, particularly when tapering was gradual, and lifestyle support was in place
"I had a provider yesterday who said, 'I'm really scared to write 12 months for a patient
6 Challenges and future perspectives Despite the compelling preclinical evidence and promising early clinical results, the full translation of SFNs potential into reliable clinical applications faces several significant challenges
doi: 10.1007/s13300-020-00951-6 49 PackerMButlerJFilippatosGSJamalWSalsaliASchneeJet al
Widely studied in research for tissue repair, gut-lining integrity, and tendon and ligament recovery
Frequently Asked Questions How quickly will I notice results from CJC-1295 and Ipamorelin